These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3045276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N, Hand PH, Merlo G, Fujita J, Mariani-Costantini R, Thor A, Nose M, Callahan R, Schlom J.
    Cancer Res; 1987 Mar 01; 47(5):1413-20. PubMed ID: 2434216
    [Abstract] [Full Text] [Related]

  • 6. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B, Benharroch D, Prinsloo I, Cagnano E, Lamprecht SA.
    Anticancer Res; 1995 Mar 01; 15(1):211-8. PubMed ID: 7537485
    [Abstract] [Full Text] [Related]

  • 7. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K.
    Hokkaido Igaku Zasshi; 1987 Jul 01; 62(4):573-80. PubMed ID: 3315926
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical study of the ras oncogene expression in human breast lesions.
    Agnantis NJ, Petraki C, Markoulatos P, Spandidos DA.
    Anticancer Res; 1986 Jul 01; 6(5):1157-60. PubMed ID: 3541779
    [Abstract] [Full Text] [Related]

  • 9. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH, Vilasi V, Thor A, Ohuchi N, Schlom J.
    J Natl Cancer Inst; 1987 Jul 01; 79(1):59-65. PubMed ID: 3298786
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical detection of ras p21 oncoprotein in breast cancer imprints.
    Agnantis NJ, Apostolikas NA, Zolotas VG, Spandidos DA.
    Acta Cytol; 1994 Jul 01; 38(3):335-40. PubMed ID: 8191822
    [Abstract] [Full Text] [Related]

  • 11. Activated Val-12 ras p21 in cell culture fluids and mouse plasma.
    Hamer PJ, La Vecchio J, Ng S, DeLellis R, Wolfe H, Carney WP.
    Oncogene; 1991 Sep 01; 6(9):1609-15. PubMed ID: 1923528
    [Abstract] [Full Text] [Related]

  • 12. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
    Gui K.
    Zhonghua Yi Xue Za Zhi; 1990 Mar 01; 70(3):140-2, 12. PubMed ID: 2163739
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to ras oncogene p21 proteins lack immunohistochemical specificity for neoplastic epithelium in human prostate tissue.
    Varma VA, Austin GE, O'Connell AC.
    Arch Pathol Lab Med; 1989 Jan 01; 113(1):16-9. PubMed ID: 2462857
    [Abstract] [Full Text] [Related]

  • 14. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
    Matarazzo M, Faraggiana T, Donato MF, Paronetto F.
    J Exp Pathol; 1987 Jan 01; 3(3):305-15. PubMed ID: 2835467
    [Abstract] [Full Text] [Related]

  • 15. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J, Hamid R, Reddy BS.
    Cancer Res; 1997 Jan 15; 57(2):253-8. PubMed ID: 9000564
    [Abstract] [Full Text] [Related]

  • 16. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG, Sinn E, Carney WP.
    Oncogene; 1989 Aug 15; 4(8):1003-8. PubMed ID: 2474786
    [Abstract] [Full Text] [Related]

  • 17. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD.
    Am J Pathol; 1996 May 15; 148(5):1531-41. PubMed ID: 8623922
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M, Yiagnisis M, Papadimitriou K, Field JK, Spandidos DA.
    Anticancer Res; 1990 May 15; 10(5A):1127-33. PubMed ID: 2241094
    [Abstract] [Full Text] [Related]

  • 19. Preparation, characterization and properties of monoclonal antibodies against intact H-ras p21 proteins.
    Sorrentino V, Nebreda AR, Alonso T, Santos E.
    Oncogene; 1989 Feb 15; 4(2):215-22. PubMed ID: 2467247
    [Abstract] [Full Text] [Related]

  • 20. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N, Thor A, Page DL, Hand PH, Halter SA, Schlom J.
    Cancer Res; 1986 May 15; 46(5):2511-9. PubMed ID: 3084069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.